These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26910280)
1. Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase. Kim JE; Kim JH; Lee Y; Yang H; Heo YS; Bode AM; Lee KW; Dong Z Oncotarget; 2016 Mar; 7(12):14616-27. PubMed ID: 26910280 [TBL] [Abstract][Full Text] [Related]
2. Hck is a key regulator of gene expression in alternatively activated human monocytes. Bhattacharjee A; Pal S; Feldman GM; Cathcart MK J Biol Chem; 2011 Oct; 286(42):36709-23. PubMed ID: 21878628 [TBL] [Abstract][Full Text] [Related]
3. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Park EJ; Zhao YZ; Kim YC; Sohn DH Eur J Pharmacol; 2007 Mar; 559(2-3):115-23. PubMed ID: 17292878 [TBL] [Abstract][Full Text] [Related]
4. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Zhou HR; Jia Q; Pestka JJ Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366 [TBL] [Abstract][Full Text] [Related]
5. Anti‑tumor effects of bakuchiol on human gastric carcinoma cell lines are mediated through PI3K/AKT and MAPK signaling pathways. Lv L; Liu B Mol Med Rep; 2017 Dec; 16(6):8977-8982. PubMed ID: 28990045 [TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Kim JE; Lee DE; Lee KW; Son JE; Seo SK; Li J; Jung SK; Heo YS; Mottamal M; Bode AM; Dong Z; Lee HJ Cancer Prev Res (Phila); 2011 Apr; 4(4):582-91. PubMed ID: 21330379 [TBL] [Abstract][Full Text] [Related]
7. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation. Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974 [TBL] [Abstract][Full Text] [Related]
8. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway. Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814 [TBL] [Abstract][Full Text] [Related]
9. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
10. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling. Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479 [TBL] [Abstract][Full Text] [Related]
11. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400 [TBL] [Abstract][Full Text] [Related]
12. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a. Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353 [TBL] [Abstract][Full Text] [Related]
13. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542 [TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294 [TBL] [Abstract][Full Text] [Related]
15. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma. Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962 [TBL] [Abstract][Full Text] [Related]
16. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway. Xiao W; Xu Z; Chang S; Li B; Yu D; Wu H; Xie Y; Wang Y; Xie B; Sun X; Kong Y; Lan X; Bu W; Chen G; Gao L; Wu X; Shi J; Zhu W Cancer Lett; 2019 Mar; 444():45-59. PubMed ID: 30583070 [TBL] [Abstract][Full Text] [Related]
17. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells. Takada Y; Sethi G; Sung B; Aggarwal BB Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248 [TBL] [Abstract][Full Text] [Related]
18. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo. Liang M; Liu J; Ji H; Chen M; Zhao Y; Li S; Zhang X; Li J Tumour Biol; 2015 Sep; 36(9):7085-91. PubMed ID: 25874498 [TBL] [Abstract][Full Text] [Related]
19. NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival. Grun D; Adhikary G; Eckert RL Mol Carcinog; 2019 Apr; 58(4):488-499. PubMed ID: 30456845 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells. Martinelli E; Troiani T; D'Aiuto E; Morgillo F; Vitagliano D; Capasso A; Costantino S; Ciuffreda LP; Merolla F; Vecchione L; De Vriendt V; Tejpar S; Nappi A; Sforza V; Martini G; Berrino L; De Palma R; Ciardiello F Int J Cancer; 2013 Nov; 133(9):2089-101. PubMed ID: 23629727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]